WuXi Biologics (Cayman) Inc. (2269) announced that its Board of Directors will convene on March 24, 2026. The purpose of this meeting is to consider and approve the annual results for the year ended December 31, 2025, as well as to address other related matters.
According to the announcement dated February 11, 2026, the Board currently comprises executive, non-executive, and independent non-executive directors, with Dr. Ge Li serving as Chairman.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.